By making intelligent connections, we bring innovation to the needs of today’s oncology development to help you focus on the patient, manage trial complexity, and increase predictability and speed. IQVIA helps you
Oncology market approvals supported by IQVIA, August 2019-2020
Oncology drug development is moving from drug-centered to patient-centered. From dose escalation through dose optimization, IQVIA’s teams are here to help you navigate the evolving landscape and make informed decisions quickly.